Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.

British journal of cancer - 26 Jan 2004

van Roosmalen M S, Stalmeier P F M, Verhoef L C G, Hoekstra-Weebers J E H M, Oosterwijk J C, Hoogerbrugge N, Moog U, van Daal W A J

Abstract excerpt

The aim of the study was to evaluate the impact of a decision aid (DA) and its timing in women being tested for a BRCA1/2 mutation. Women with and without a previous history of cancer were included after blood sampling for genetic testing. The DA consisted of a brochure and video providing inform...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attitude to Health
Share to Decision Making
Share to Decision Support Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Mastectomy

Share to Patient Education as Topic

Share to Video Recording

Source

Open in PubMed Open full text

Identifiers

PMID: 14735173
DOI: 10.1038/sj.bjc.6601525
PMCID: PMC2410151

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-14735173-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.PMID 14735173Read ↗

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.Semantic proximity Read ↗

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.Semantic proximity Read ↗

Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.Semantic proximity Read ↗

Longitudinal Changes in Patient Distress following Interactive Decision Aid Use among BRCA1/2 CarriersSemantic proximity Read ↗

Are we ready for online tools in decision making for BRCA1/2 mutation carriers?Semantic proximity Read ↗

Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.Semantic proximity Read ↗

Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).Semantic proximity Read ↗

The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study.Semantic proximity Read ↗

Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.